CRISIL Limited (BOM:500092)
4,180.50
-11.35 (-0.27%)
At close: Mar 25, 2025
CRISIL Revenue
In the year 2024, CRISIL had annual revenue of 32.60B INR with 3.83% growth. CRISIL had revenue of 9.13B in the quarter ending December 31, 2024, a decrease of -0.53%.
Revenue
32.60B
Revenue Growth
+3.83%
P/S Ratio
n/a
Revenue / Employee
6.98M
Employees
4,673
Market Cap
305.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 32.60B | 1.20B | 3.83% |
Dec 31, 2023 | 31.40B | 3.71B | 13.39% |
Dec 31, 2022 | 27.69B | 4.68B | 20.34% |
Dec 31, 2021 | 23.01B | 3.19B | 16.09% |
Dec 31, 2020 | 19.82B | 2.50B | 14.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
HDFC Bank | 2,702.59B |
Tata Consultancy Services | 2,520.82B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 1,755.26B |
State Bank of India | 3,409.52B |
Infosys | 1,635.60B |
Bajaj Finance | 358.05B |
CRISIL News
- 7 weeks ago - Crisil shares drop over 8% as Q3 revenue declines - Business Upturn
- 7 weeks ago - Crisil Q3 Results: Revenue down 0.5% to Rs 912.91 crore, Net Profit up 7.03% YoY - Business Upturn
- 2 months ago - Top gainers today: Piramal Pharma surges 5.85%, CRISIL rises 3.63%, Aditya Birla Capital gains 2.76%, AstraZeneca Pharma up 2.57% - Business Upturn
- 3 months ago - CRISIL invests Rs 33.25 Crore in online PSB Loans - Business Upturn